EDN1 and Hypertension: However, since the presence of L-NAME produced a further slight decrease in ACh-induced vasorelaxation than that observed with Su treatment alone, factors other than NO might also play a role in the genesis of hypertension in the context of Su treatment; these factors include oxidative stress, ET-1, and gene polymorphisms [15,34].